Bypassing CFTR dysfunction in cystic fibrosis with alternative pathways for anion transport.
about
Ion Channel Modulators in Cystic FibrosisRecent advances in developing therapeutics for cystic fibrosisRole of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic FibrosisPhysiological and Pathophysiological Relevance of the Anion Transporter Slc26a9 in Multiple OrgansAnion-Transport Mechanism of a Triazole-Bearing Derivative of Prodigiosine: A Candidate for Cystic Fibrosis TherapySpecialized Pro-Resolving Lipid Mediators in Cystic Fibrosis
P2860
Bypassing CFTR dysfunction in cystic fibrosis with alternative pathways for anion transport.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Bypassing CFTR dysfunction in ...... pathways for anion transport.
@en
Bypassing CFTR dysfunction in ...... pathways for anion transport.
@nl
type
label
Bypassing CFTR dysfunction in ...... pathways for anion transport.
@en
Bypassing CFTR dysfunction in ...... pathways for anion transport.
@nl
prefLabel
Bypassing CFTR dysfunction in ...... pathways for anion transport.
@en
Bypassing CFTR dysfunction in ...... pathways for anion transport.
@nl
P2093
P1476
Bypassing CFTR dysfunction in ...... pathways for anion transport.
@en
P2093
David N Sheppard
Johanna J Salomon
Luis Jv Galietta
Marcus A Mall
P356
10.1016/J.COPH.2017.10.002
P577
2017-10-21T00:00:00Z